Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.
Saved in:
| Title: | Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study. |
|---|---|
| Authors: | Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy. Electronic address: mario.mandala@unipg.it., Amaral T; Skin Cancer Clinical Trials Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Sergi MC; Unit of Medical Oncology, 'Mons. A.R. Dimiccoli' Hospital, Asl BT, Viale Ippocrate, 15, Barletta, BT 70051, Italy., Rasch ML; Skin Cancer Clinical Trials Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Benannoune N; Gustave Roussy Cancer Campus, Villejuif, France., Serra P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy., Giannarelli D; Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Arance AM; Hospital Clínic Barcelona and IDIBAPS, Barcelona 08036, Spain., Couselo EM; Department of medical oncology. Vall d'Hebron Hospital, Barcelona, Spain & Vall d'Hebron Institute of oncology (VHIO), Barcelona, Spain., Neyns B; Department of Medical Oncology, UZ Brussel, Brussels, Belgium., Dirven I; Department of medical oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Tucci M; Medical Oncology Unit, University of Bari Aldo Moro, Policlinico Hospital of Bari, Bari 70124, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II', Bari, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy., Rossi E; Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Queirolo P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Quaglino P; Department of Dermatology, University of Turin, Turin, Italy., Depenni R; University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy., Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Giacomo AMD; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Indini A; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Silva IPD; Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Hong A; Department of Radiation Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales 2050, Australia; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Australia., Lorigan P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115567. Date of Electronic Publication: 2025 Jun 09. |
| Publication Type: | Comparative Study; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40505525 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mandalà+M%22">Mandalà M</searchLink>; Unit of Medical Oncology, University of Perugia, Perugia, Italy. Electronic address: mario.mandala@unipg.it.<br /><searchLink fieldCode="AU" term="%22Amaral+T%22">Amaral T</searchLink>; Skin Cancer Clinical Trials Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rutkowski+P%22">Rutkowski P</searchLink>; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Sergi+MC%22">Sergi MC</searchLink>; Unit of Medical Oncology, 'Mons. A.R. Dimiccoli' Hospital, Asl BT, Viale Ippocrate, 15, Barletta, BT 70051, Italy.<br /><searchLink fieldCode="AU" term="%22Rasch+ML%22">Rasch ML</searchLink>; Skin Cancer Clinical Trials Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Benannoune+N%22">Benannoune N</searchLink>; Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Serra+P%22">Serra P</searchLink>; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK.<br /><searchLink fieldCode="AU" term="%22Vitale+MG%22">Vitale MG</searchLink>; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Giannarelli+D%22">Giannarelli D</searchLink>; Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Arance+AM%22">Arance AM</searchLink>; Hospital Clínic Barcelona and IDIBAPS, Barcelona 08036, Spain.<br /><searchLink fieldCode="AU" term="%22Couselo+EM%22">Couselo EM</searchLink>; Department of medical oncology. Vall d'Hebron Hospital, Barcelona, Spain & Vall d'Hebron Institute of oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Neyns+B%22">Neyns B</searchLink>; Department of Medical Oncology, UZ Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Dirven+I%22">Dirven I</searchLink>; Department of medical oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Tucci+M%22">Tucci M</searchLink>; Medical Oncology Unit, University of Bari Aldo Moro, Policlinico Hospital of Bari, Bari 70124, Italy.<br /><searchLink fieldCode="AU" term="%22Guida+M%22">Guida M</searchLink>; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Spagnolo+F%22">Spagnolo F</searchLink>; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Rossi+E%22">Rossi E</searchLink>; Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Queirolo+P%22">Queirolo P</searchLink>; IEO European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Quaglino+P%22">Quaglino P</searchLink>; Department of Dermatology, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Depenni+R%22">Depenni R</searchLink>; University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy.<br /><searchLink fieldCode="AU" term="%22Placzke+J%22">Placzke J</searchLink>; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Giacomo+AMD%22">Giacomo AMD</searchLink>; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Del+Vecchio+M%22">Del Vecchio M</searchLink>; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Indini+A%22">Indini A</searchLink>; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Silva+IPD%22">Silva IPD</searchLink>; Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Hong+A%22">Hong A</searchLink>; Department of Radiation Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales 2050, Australia; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Lorigan+P%22">Lorigan P</searchLink>; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Robert+C%22">Robert C</searchLink>; Gustave Roussy and Paris-Saclay University, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ascierto+PA%22">Ascierto PA</searchLink>; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115567. <i>Date of Electronic Publication: </i>2025 Jun 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40505525 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2025.115567 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 115567 Titles: – TitleFull: Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mandalà M – PersonEntity: Name: NameFull: Amaral T – PersonEntity: Name: NameFull: Rutkowski P – PersonEntity: Name: NameFull: Sergi MC – PersonEntity: Name: NameFull: Rasch ML – PersonEntity: Name: NameFull: Benannoune N – PersonEntity: Name: NameFull: Serra P – PersonEntity: Name: NameFull: Vitale MG – PersonEntity: Name: NameFull: Giannarelli D – PersonEntity: Name: NameFull: Arance AM – PersonEntity: Name: NameFull: Couselo EM – PersonEntity: Name: NameFull: Neyns B – PersonEntity: Name: NameFull: Dirven I – PersonEntity: Name: NameFull: Tucci M – PersonEntity: Name: NameFull: Guida M – PersonEntity: Name: NameFull: Spagnolo F – PersonEntity: Name: NameFull: Rossi E – PersonEntity: Name: NameFull: Queirolo P – PersonEntity: Name: NameFull: Quaglino P – PersonEntity: Name: NameFull: Depenni R – PersonEntity: Name: NameFull: Placzke J – PersonEntity: Name: NameFull: Giacomo AMD – PersonEntity: Name: NameFull: Del Vecchio M – PersonEntity: Name: NameFull: Indini A – PersonEntity: Name: NameFull: Silva IPD – PersonEntity: Name: NameFull: Menzies AM – PersonEntity: Name: NameFull: Hong A – PersonEntity: Name: NameFull: Lorigan P – PersonEntity: Name: NameFull: Long GV – PersonEntity: Name: NameFull: Robert C – PersonEntity: Name: NameFull: Ascierto PA IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 07 Text: 2025 Jul 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 225 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |
